These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 385296)

  • 21. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind trial: vivalan against placebo in depressed elderly patients.
    Von Knorring L
    J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of viloxazine (author's transl)].
    Brunner H; Huck F
    Encephale; 1980; 6(3):247-57. PubMed ID: 7449724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
    [No Abstract]   [Full Text] [Related]  

  • 28. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of schizophrenia without symptoms with viloxazine].
    Kornhuber HH; Lisson G; Rissotto R
    Dtsch Med Wochenschr; 1985 Apr; 110(17):698. PubMed ID: 3886343
    [No Abstract]   [Full Text] [Related]  

  • 30. A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression.
    Kiloh LG; Bartrop RW; Franklin JA; Neilson MD
    Aust N Z J Psychiatry; 1979 Dec; 13(4):357-60. PubMed ID: 395939
    [No Abstract]   [Full Text] [Related]  

  • 31. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jun; 13(6):401-21. PubMed ID: 324751
    [No Abstract]   [Full Text] [Related]  

  • 32. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic use of viloxazine (Vivalan ICI) in depressed hospital out-patients (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1976 Dec; 72(6):384-9. PubMed ID: 1000703
    [No Abstract]   [Full Text] [Related]  

  • 34. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viloxazine in the treatment of depressive states.
    Rydzyński Z; Gruszczyński W
    Act Nerv Super (Praha); 1979 Oct; 21(3):146-7. PubMed ID: 556241
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vivalan (viloxazine)].
    Chevalier JF
    Ann Med Psychol (Paris); 1979; 137(3-4):363-6. PubMed ID: 496167
    [No Abstract]   [Full Text] [Related]  

  • 37. Viloxazine in depressed women: clinical response and cardiovascular effects.
    Corona GL; Frattini P; Cucchi ML; Santagostino G; Schinelli S; Zerbi F; Cairoli S; Tosca P; Savoldi F
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):322-7. PubMed ID: 3623737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amoxapine and viloxazine: review of the literature with special reference to clinical studies.
    Ban TA
    Psychopharmacol Bull; 1979 Jul; 15(3):22-5. PubMed ID: 386404
    [No Abstract]   [Full Text] [Related]  

  • 40. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.